Rapid Micro Biosystems, Inc.
RPID- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001380106
No open-market purchases or sales by Rapid Micro Biosystems, Inc. insiders were filed in the last 90 days; 34 institutions reported holding it in 13F filings for Q2 2026, worth $30.3M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Rapid Micro Biosystems, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- −3 vs. Q4 2023
- Shares held
- 19.1M
- −1.04M (−5.2%) vs. Q4 2023
- Total value
- $18.2M
- +$3.37M (+22.7%) vs. Q4 2023
- New holders
- 1
- 5 more added
- Sold out
- 4
- 8 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RPID on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 34 | $30.3M |
| Q1 2026 | 46 | $36.0M |
| Q4 2025 | 42 | $42.5M |
| Q3 2025 | 29 | $49.5M |
| Q2 2025 | 29 | $52.3M |
| Q1 2025 | 28 | $40.4M |
| Q4 2024 | 19 | $10.8M |
| Q3 2024 | 19 | $15.6M |
| Q2 2024 | 21 | $12.2M |
| Q1 2024 | 23 | $18.2M |
| Q4 2023 | 26 | $14.9M |
| Q3 2023 | 23 | $23.2M |
| Q2 2023 | 24 | $21.9M |
| Q1 2023 | 31 | $29.9M |
| Q4 2022 | 42 | $27.7M |
| Q3 2022 | 53 | $82.8M |
| Q2 2022 | 52 | $112.2M |
| Q1 2022 | 59 | $181.0M |
| Q4 2021 | 55 | $227.9M |
| Q3 2021 | 49 | $401.4M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Rapid Micro Biosystems, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Resources Management Corp | 500 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 60 | $0 | 0.00% | −190−76.0% | Reduced |
| Qube Research & Technologies Ltd | 4 | $4 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 83 | $81 | 0.00% | +69+492.9% | Added |
| Wells Fargo & Company | 157 | $152 | 0.00% | +3+1.9% | Added |
| UBS Group AG | 246 | $239 | 0.00% | +246 | New |
| Tower Research Capital LLC (TRC) | 5,547 | $5.38K | 0.00% | −4,260−43.4% | Reduced |
| Morgan Stanley | 10,108 | $9.80K | 0.00% | −536−5.0% | Reduced |
| Virtu Financial LLC | 10,880 | $11.0K | 0.00% | −5,184−32.3% | Reduced |
| Northern Trust Corp | 15,650 | $15.2K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 18,639 | $18.1K | 0.00% | −199,648−91.5% | Reduced |
| State Street Corp | 26,074 | $25.3K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 57,387 | $56.0K | 0.00% | −20,500−26.3% | Reduced |
| Millennium Management LLC | 66,187 | $64.2K | 0.00% | +49,012+285.4% | Added |
| Geode Capital Management, LLC | 161,153 | $156.4K | 0.00% | +5,889+3.8% | Added |
| Advent International Corp | 577,777 | $560.4K | 0.01% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 622,831 | $604.1K | 0.00% | −128,481−17.1% | Reduced |
| Vanguard Group Inc | 728,484 | $706.6K | 0.00% | +1100.0% | Added |
| ABG-WTT Global Life Science Capital Partners GP Ltd | 1,038,296 | $768.3K | 1.85% | 00.0% | Unchanged |
| BlackRock Inc. | 1,019,728 | $989.1K | 0.00% | −1,729−0.2% | Reduced |
| Glenview Capital Management, LLC | 1,318,288 | $1.28M | 0.02% | 00.0% | Unchanged |
| Kennedy Lewis Management LP | 4,939,931 | $4.79M | 20.73% | 00.0% | Unchanged |
| Bain Capital Life Sciences Investors, LLC | 8,434,560 | $8.18M | 0.66% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −700,000−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −24,135−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −10,463−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |